Cite
Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors.
MLA
Metwally, Nadia Hanafy, et al. “Synthesis, Anticancer Evaluation, Molecular Docking and ADME Study of Novel Pyrido[4ʹ,3ʹ:3,4]Pyrazolo[1,5-a]Pyrimidines as Potential Tropomyosin Receptor Kinase A (TrKA) Inhibitors.” BMC Chemistry, vol. 18, no. 1, Apr. 2024, pp. 1–26. EBSCOhost, https://doi.org/10.1186/s13065-024-01166-7.
APA
Metwally, N. H., Deeb, E. A., & Hasani, I. W. (2024). Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors. BMC Chemistry, 18(1), 1–26. https://doi.org/10.1186/s13065-024-01166-7
Chicago
Metwally, Nadia Hanafy, Emad Abdullah Deeb, and Ibrahim Walid Hasani. 2024. “Synthesis, Anticancer Evaluation, Molecular Docking and ADME Study of Novel Pyrido[4ʹ,3ʹ:3,4]Pyrazolo[1,5-a]Pyrimidines as Potential Tropomyosin Receptor Kinase A (TrKA) Inhibitors.” BMC Chemistry 18 (1): 1–26. doi:10.1186/s13065-024-01166-7.